synarel- nafarelin acetate spray, metered
pfizer laboratories div pfizer inc - nafarelin acetate (unii: 8enz0qjw4h) (nafarelin - unii:1x0094v6jv) - nafarelin 2 mg in 1 ml - (for endometriosis, see reverse side ) synarel is indicated for treatment of central precocious puberty (cpp) (gonadotropin-dependent precocious puberty) in children of both sexes. the diagnosis of central precocious puberty (cpp) is suspected when premature development of secondary sexual characteristics occurs at or before the age of 8 years in girls and 9 years in boys, and is accompanied by significant advancement of bone age and/or a poor adult height prediction. the diagnosis should be confirmed by pubertal gonadal sex steroid levels and a pubertal lh response to stimulation by native gnrh. pelvic ultrasound assessment in girls usually reveals enlarged uterus and ovaries, the latter often with multiple cystic formations. magnetic resonance imaging or ct-scanning of the brain is recommended to detect hypothalamic or pituitary tumors, or anatomical changes associated with increased intracranial pressure. other causes of sexual precocity, such as congenital adrenal hyperplasia, testotoxicosis, testicular
gonazon
intervet international bv - azagly-nafarelin - pituitary and hypothalamic hormones and analogues - dogs; salmonidae (salmonid fish) - female salmonid fish such as atlantic salmon (salmo salar), rainbow trout (oncorhynchus mykiss), brown trout (salmo trutta) and arctic charr (salvelinus alpinus)induction and synchronisation of ovulation for the production of eyed-eggs and fry.dogs (bitches)prevention of gonadal function in bitches via long term blockade of gonadotrophin synthesis.
synarel metered-dose aerosol
pfizer canada ulc - nafarelin (nafarelin acetate) - metered-dose aerosol - 200mcg - nafarelin (nafarelin acetate) 200mcg - gonadotropins and antigonadotropins
synarel nasal spray nafarelin (as acetate) 2mg/ml
pfizer australia pty ltd - nafarelin, quantity: 2 mg/ml - spray, solution - excipient ingredients: benzalkonium chloride; sorbitol; glacial acetic acid; hydrochloric acid; purified water; sodium hydroxide - indications as at 31 august 1995. synarel is indicated for the hormonal management of visually proven endometriosis, including pain relief and reduction of endometriotic lesions and for use in controlled ovarian stimulation programmes prior to in-vitro fertilisation, under the supervision of an infertility specialist.
synarel
pfizer pfe pharmaceuticals israel ltd - nafarelin acetate - nasal solution - nafarelin acetate 2 mg/ml - nafarelin - nafarelin - - controlled ovarian stimulation programmes prior to in-vitro fertilisation.- hormonal management of endometriosis, including pain relief and reduction of endometrial lesions. - uterine fibroids.
synarel
pfizer pfe pharmaceuticals israel ltd - nafarelin acetate - nasal solution - nafarelin acetate 2 mg/ml - nafarelin - - controlled ovarian stimulation programmes prior to in-vitro fertilisation.- hormonal management of endometriosis, including pain relief and reduction of endometrial lesions. - uterine fibroids.
nafarelin nasal spray 0.2% "f" (ナファレリン点鼻液0.2%「f」)
fuji pharmaceutical co.,ltd. - nafarelin acetate hydrate - limpid and colorless nasal solution
synarel 200micrograms/dose nasal spray
pfizer ltd - nafarelin acetate - spray - 200microgram/1dose
synarel 200 micrograms/dose nasal spray solution
pfizer healthcare ireland - nafarelin - nasal spray, solution - 200 mcg/dose - gonadotropin-releasing hormones; nafarelin
synarel
pharmacia limited company trading as pharmacia - nafarelin acetate hydrate equivalent to 2 mg/ml nafarelin free base - nasal spray solution - 200 mcg/dose - active: nafarelin acetate hydrate equivalent to 2 mg/ml nafarelin free base excipient: benzalkonium chloride glacial acetic acid hydrochloric acid purified water sodium hydroxide sorbitol